공지사항

Myelodysplastic Syndrome Lawsuit Settlement

Myelodysplastic Syndrome is a blood disorder that results in low blood cell counts. It is often a precursor to acute myelogenous leukemia.

It could affect bone marrow and blood cells. You may have fewer red blood cells and white blood cells. You may also have fewer platelets.

MDS patients can live with chemotherapy, medication, or a stem cell transplant. Multiple studies have found that exposure to TCE and PCE at Camp Lejeune to MDS.

Compensation

MDS is when cells that are not mature in the bone marrow don't develop into healthy blood cells. This results in the body being deficient in healthy white and red blood cells, as well as platelets which aid in blood clot. The symptoms of MDS include weakness, fatigue, weight loss, and bone pain. It can also cause the lower than normal amount of blood cells, which can cause severe anemia. Other signs include frequent infections, easy or unusual bleeding (a indication that platelet counts are low) and Myelodysplastic Syndrome railroad Injuries tiny red spots on the body, caused by bleeding that occurs beneath the skin's surface (petechiae).

MDS is not cancerous, but it can progress into leukemia. It can be difficult to treat.

Under the Camp Lejeune Justice Act, anyone who resided, served or worked at the Marine Corps Base Camp Lejeune for a minimum of 30 consecutive days between 1953 and 1987 may be legally able to file a lawsuit if they have been diagnosed with one of the Myelodysplastic Syndrome cancer settlements syndromes or related blood diseases linked to benzene exposure.

Every patient with MDS or other myelodysplastic syndrome mds disorders is unique and has its own distinct genes and the molecules that cause the disease. OSUCCC-James experts such as hematologists, subspecialists and other specialists, Myelodysplastic Syndrome Railroad Injuries make use of their expertise to design an individual treatment plan. This could include chemotherapy, stem cell or bone marrow transplants, blood transfusions or access to clinical trial right here in the hospital.

Damages

Myelodysplastic syndromes (MDS) are a set of disorders that affect blood-forming cells within the bone marrow. These abnormal cells hinder the development of healthy blood cells. They can result in a shortage of red blood cells (anemia) as well as platelets (thrombocytopenia) or white blood cells (leukopenia).

MDS is often treated by increasing blood count via stem cell transplants, bone marrow transplant and blood-cell growth factors and chemotherapy. Treatment is individualized to the needs of the patient and differs based on the nature of MDS.

Compensation for those who suffer from Myelodysplastic Syndrome railroad cancer disorder includes medical bills loss of income, as well as future financial needs. Victims can also receive compensation for mental distress as well as non-economic damages.

In July 2011, the decedent began to visit the hematologist who was the defendant for anemia that had no clear cause. The hematologist suggested that it could be early Myelodysplastic Syndrome Railroad Injuries syndrome, but didn't perform an marrow bone biopsy, instead opting to monitor the patient and stating she would do the procedure if there were further drops in his hematocrit.

Benzene is a known carcinogen is believed to be the cause of cancers such as myelodysplastic and other cancers. Railroad workers are especially at risk of developing myelodysplastic Syndrome and other types of cancer because they are frequently exposed to benzene during their work. Joe Lyon is a highly Rated Toxic Tort Lawyer reviewing benzene exposure and myelodysplastic syndrome related lawsuits on behalf of people across the nation.

Time for Litigation

The litigation time involved in the settlements of myelodysplastic disorder lawsuits will depend on the number of claims that are filed. The Congressional Budget Office (a flawed bureaucracy but the best government agency for predicting costs) has projected $22 billion in total settlement amounts.

The victims are seeking compensation for their medical bills and lost wages because of working hours they missed due to treatment. Families of victims also seek compensation for the emotional trauma that was caused to them by the disease.

Our lawyers are currently reviewing railroad worker cases for Myelodysplastic Syndrome settlement disorder and leukemia as well as other illnesses that are presumed to be related to exposure to benzene in the workplace. Complete our online form if been diagnosed with cancer or another illness while working on the railway. We will review your claim immediately and at no cost.

Attorney Fees

Anyone who lived or worked on the Camp Lejeune military base between 1953 and 1987 has the right under the Camp Lejeune Justice Act to file a suit. This includes people who developed myelodysplastic syndrome (MDS) or other blood cancers due to exposure to the water that was contaminated.

Myelodysplastic Syndrome occurs when abnormal blood-forming cell types in the bone marrow do not function properly, resulting in low blood cell counts. The condition can develop into acute myeloid leukemia, which is a more serious form of bone marrow cancer.

Symptoms can include feeling tired, having a pale complexion and a slurred breath. In addition, a peripheral blood smear could reveal changes in the amount and type of red blood cells as well as white blood cells and platelets. These tests can assist doctors determine the severity of the myelodysplastic disease and determine the most effective treatment.

MDS is treated with chemotherapy and blood transfusions. Stem cell transplants are also an option. It is also important to monitor the condition to determine if the condition progresses or becomes more severe. Treatment for MDS depends on the type of disease, and patients can be treated for a variety of types at once. Learn more about myelodysplastic syndrome and other blood cancers by visiting the PDQ cancer information summary from the National Institutes of Health. This site is updated and provides accurate information about cancer to aid you in making informed choices about your health.